Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
Hologic (HOLX) reachead $75.36 at the closing of the latest trading day, reflecting a -0.03% change compared to its last close.
Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail
Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know
Hologic (HOLX) concluded the recent trading session at $77.38, signifying a -0.77% move from its prior day's close.
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024.
Hologic (HOLX) Ascends While Market Falls: Some Facts to Note
Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.
Hologic (HOLX) Rises But Trails Market: What Investors Should Know
Hologic (HOLX) concluded the recent trading session at $76.35, signifying a +0.58% move from its prior day's close.
Hologic (HOLX) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Hologic (HOLX) closed at $75.64, marking a -0.9% move from the previous day.
Hologic's (HOLX) BCI Genomic Test Study Outcome Favorable
Hologic's (HOLX) BCI test is the only genomic test that is approved by various national oncology guidelines.
FDA warns of potential risk of complications with use of Hologic's devices
The U.S. Food and Drug Administration on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic's devices that are implan...
Hologic: Prospects For Growth As Headwinds Disappear
Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales. The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds ther...
Hologic (HOLX) Introduces Genius Digital Diagnostics System
Hologic's (HOLX) Genius Digital Diagnostics System will assist laboratories and healthcare providers with the information needed to make more timely and successful treatment decisions for patients.
Hologic CEO on Q1 earnings, AI in health care
Steve MacMillan, Hologic CE, joins 'Money Movers' to discuss the company's new AI cervical screening system, Hologic's quarterly earnings results, and more.
Hologic's (HOLX) Q1 Earnings Beat Estimates, Gross Margin Down
Hologic's (HOLX) Breast Health segment registered strong growth in Q1, primarily owing to higher capital equipment revenues.
Related Companies